See also this year's filing and all EDGAR filings for this company.
PDF Report 0001355250_2021_Innovation_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001355250, Innovation Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,110,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,060,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 78,000 |
| 4 | LiabilitiesCurrent | 7,369,000 |
| 5 | LiabilitiesNoncurrent | 417,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,437,519 |
| 9 | ResearchAndDevelopmentExpense | 2,373,508 |
| 10 | remainder_Expenses | 3,809,211 |
| 11 | remainder_Revenues | 423,000 |
| 12 | remainder_NetIncome | -8,246,646 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 9,248,000 |
| 1 | Liabilities | 7,786,000 |
| 2 | Expenses | 7,620,238 |
| 3 | Revenues | 423,000 |
| 4 | StockholdersEquity | 1,462,000 |
| 5 | NetIncome | -15,443,884 |
| 6 | ComprehensiveNetIncome | -15,443,884 |
| 7 | BaseVar | 16,661,942 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.44 |
| 9 | EconomicCapitalRatio | 1.20 |